08:51 AM EST, 02/26/2025 (MT Newswires) -- Vera Therapeutics ( VERA ) reported a 2024 net loss Wednesday of $2.75 per diluted share, widening from a loss of $2.25 a year earlier.
Analysts polled by FactSet expected a loss of $2.90.
The clinical-stage biopharmaceutical firm did not report any revenue.
The company reported cash and cash equivalents of $640.9 million as of Dec. 31, up from $160.7 million a year earlier.